Clinical Trials Logo

Clinical Trial Summary

Retrospective study based on medical records of patients with multiple myeloma, eligible for stem cell transplantation, who received, first-line, the VTD or TD combination.


Clinical Trial Description

The most current treatment of multiple myeloma is based on a combination of drugs, including immunomodulators, proteasome inhibitors, etc. The VTD (bortezomib, thalidomide, and dexamethasone) and TD (thalidomide and dexamethasone) regimens are commonly used as a first-line treatment due to limited resources. The study aimed to compare the proportion of favorable responses, survival, and time to the next treatment between two different treatment approaches. The investigators designed a retrospective study based on medical records of patients with multiple myeloma, eligible for stem cell transplantation, who received, first-line, the VTD or TD combination. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT06284395
Study type Observational
Source Hospital General de Mexico
Contact Christian O Ramos Peñafiel, PhD
Phone +52 55 27892000
Email leukemiachop33@gmail.com
Status Recruiting
Phase
Start date November 20, 2023
Completion date March 30, 2024

See also
  Status Clinical Trial Phase
Recruiting NCT05540392 - An Acupuncture Study for Prostate Cancer Survivors With Urinary Issues Phase 1/Phase 2
Recruiting NCT05540782 - A Study of Cognitive Health in Survivors of Prostate Cancer
Completed NCT04337203 - Shared Healthcare Actions and Reflections Electronic Systems in Survivorship N/A
Active, not recruiting NCT05796518 - Feasibility of a Patient Directed Tool to Assess Heart Health Among Endometrial Cancer Survivors N/A
Active, not recruiting NCT06015009 - Symptom Management App for Children at the Early Stage of Cancer Survivorship and Their Caregivers N/A
Active, not recruiting NCT05837169 - Randomized Study to Evaluate an Intervention Based on Mindfulness to Reduce Anxiety in Breast Cancer Survivors N/A
Completed NCT04601090 - Survival Rates and Longterm Outcomes After COVID-19
Completed NCT04066218 - Sexual Function Screening in Childhood Cancer Survivors
Not yet recruiting NCT05020561 - Life After Breast Cancer - Impact of a Life Coach N/A
Recruiting NCT05863702 - Staying Healthy With Follow-up Care: A Mobile Chatbot Feasibility Study for AYA Cancer Survivors N/A
Recruiting NCT04898855 - Internet-delivered Cognitive-Behavioral Intervention for Insomniac Cancer Survivors N/A
Recruiting NCT05574127 - A Study of Brief Behavioral Activation for the Treatment of Depression in Older Adult Cancer Survivors Phase 2
Active, not recruiting NCT04918082 - Assessment of Quality of Life and Treatment Times for Patients With Invasive Type Breast Cancer in Martinique
Completed NCT04596865 - Recurrence After Whipple's (RAW) Study
Recruiting NCT05611307 - Late Subclinical Cardiovascular Disease in Testicular Cancer Survivors
Completed NCT04758026 - H&N Cancer; Survivorship and Late Effects
Recruiting NCT04547634 - Telerehabilitation in Oncology Patients N/A
Recruiting NCT04014309 - Accessible Cancer Care to Enable Support for Survivors Programme N/A
Completed NCT05610982 - A Yoga Program for Adults Diagnosed With Gynecologic Cancer N/A
Completed NCT05121259 - Feasibility and Acceptability of an Web-based Physical Activity Program, for Those Diagnosed With Lung Cancer. N/A